CDC says American tests positive for Ebola in Africa, risk in the U.S. remains low
No cases tied to the Ebola outbreak have been confirmed in the U.S., and the overall risk to the American public and travelers remains low....
Category : Business
Lululemon takes battle with Chip Wilson public, calls founder ‘misguided’ and ‘outdated’
Lululemon responded publicly to founder Chip Wilson’s campaign in a letter to shareholders, where it urged them to vote in its favor at its annual...
Creator content made the main stage at TV’s ‘upfront’ pitches — and not just for YouTube
In media companies’ annual pitch to advertisers this week, creator content played a bigger role as a new category for reaching younger audiences....
Chinese EVs are coming to Canada, and some dealers can’t wait to sell them
Canada is allowing 49,000 Chinese-made electric vehicles to be imported for retail sales annually at a tariff rate of 6.1%....
Detroit automakers have cut more than 20,000 U.S. salaried jobs as AI threat looms
Reasons for the job declines vary by automaker, but are generally tied to evolving technological changes in the industry — including the rise of AI....
CDC says there are no U.S. hantavirus cases currently, 41 people being monitored
The CDC said the risk to the general public from hantavirus remains low....
China will order 200 Boeing jets, Trump tells Fox News
President Donald Trump told Fox News that China has agreed to buy 200 Boeing jets, according to a clip that aired Thursday....
Hantavirus outbreak isn’t another Covid pandemic – but experts say it’s testing U.S. readiness
For some experts, the outbreak is raising broader concerns about how equipped the U.S. is to respond to future infectious disease threats....
Allegiant CEO makes case for low-cost airline model as Sun Country acquisition closes
Allegiant CEO Greg Anderson said leisure travel demand is still strong despite higher fuel prices....
Marty Makary resigns as FDA commissioner following industry and White House backlash
Makary’s tenure was marked by internal dysfunction at the FDA, leadership turmoil and mounting backlash from drugmakers and physicians on regulatory decisions....